Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone for Driving in Young Adults with ASD
NCT03538431Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of buspirone in Autism Spectrum Disorder (ASD), sponsored by Massachusetts General Hospital. Started Oct 2018; status: completed.
02
Drugs
buspirone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03538431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03538431.